Corpus Intelligence IC Memo — CONTINUED CARE HOSPITAL JONESBORO 2026-04-26 06:36 UTC
IC Memo — CONTINUED CARE HOSPITAL JONESBORO
Investment Committee Memorandum | AR | 99 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CONTINUED CARE HOSPITAL JONESBORO

CCN 042013 | CRAIGHEAD, AR | 99 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CONTINUED CARE HOSPITAL JONESBORO is a 99-bed rural/critical access in CRAIGHEAD, AR with $17.3M in net patient revenue and a -15.9% operating margin. The hospital serves a payer mix of 51.9% Medicare, 0.6% Medicaid, and 47.6% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.9% to -8.5% (+736bps).

Net Revenue HCRIS$17.3M
Current EBITDA COMPUTED$-2.8M
Operating Margin COMPUTED-15.9%
Occupancy HCRIS33.1%
Revenue / Bed COMPUTED$175K
Net-to-Gross HCRIS25.0%
Distress Probability ML53.2%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
32
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -15.9% places it below the state median. Among 32 size-comparable peers (50-198 beds), the median margin is 1.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-198), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CONTINUED CARE HOSPITAL JONESB (Target)AR99$17.3M-15.9%
BAXTER REGIONAL MEDICAL CENTERAR169$282.2M-2.8%
WHITE COUNTY MEDICAL CENTERAR179$251.3M3.4%
WHITE RIVER MEDICAL CENTERAR170$247.7M-11.9%
NEA BAPTIST MEMORIAL HOSPITALAR180$246.7M1.0%
CONWAY REGIONAL MEDICAL CENTERAR169$232.9M-14.5%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$364K+210bp18mo
Cost to Collect4.5%2.5%$346K+200bp12mo
Denial Rate Reduction12.0%6.5%$343K+198bp12mo
A/R Days Reduction5200.0%3800.0%$211K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$364K
Cost to Collect
$346K
Denial Rate Reduction
$343K
A/R Days Reduction
$211K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$-2.8M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$-1.5M
Current Margin-15.9%
Pro Forma Margin-8.5%
WC Released (1x)$664K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.2M$-5.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.2M$-7.3M0.00x-100.0%
Bull Case9.0x11.0x$-3.8M$-4.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.8M$-6.0M0.00x-100.0%
Bear Case11.0x10.0x$-4.7M$-10.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.7M$-13.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 33.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 53.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 50-198 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-11.8% / P50=1.1% / P75=7.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.